Financial Daily from THE HINDU group of publications
Saturday, Nov 27, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Preferential Allotments


Neuland Labs calls EGM for pref allotment

Our Bureau

Hyderabad , Nov. 26

NEULAND Laboratories Ltd (NLL), the city-based pharmaceutical company. has informed stock exchanges that its extraordinary general meeting (EGM) would be held on December 17 to obtain the approval of shareholders for the proposed preferential offer to the promoters and others.

The company proposes to issue not exceeding 2.75 lakh warrants to the promoters Dr D.R. Rao and Sucheth & Saharsh Holdings Pvt Ltd on preferential allotment basis in one or more tranches.

Each warrant entitles the holder to one equity share of Rs 10 each at a premium of Rs 238.20 aggregating Rs 6.82 crore.

The conversion into equity shares would be made within a period not exceeding eighteen months from the date of allotment of the warrants, the company said.

More Stories on : Preferential Allotments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Indian Immunologicals launches Nimesulide injection for animals


Hyundai drops prices of Elantra
MetalJunction goes for a changeover
Neuland Labs calls EGM for pref allotment
`Reliance Ind board had rejected Anil Ambani's contention'
Birla case hearing to resume on Dec 1
JK Ind bags award
DCM Shriram to retail BPCL petrol — In talks with ICICI Bank for extension counters
Tops Security plans to offer stake to foreign investor
AAIFR stays winding up of Pennar Profiles
Addl capital from Kothari Sugars promoters for revival
Essel Propack upbeat on plastic tubes business
Wanbury's technical head



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line